Some treatments, such as monoclonal tau antibodies and active tau vaccines are showing early promise (Cummings et al., 2019; Jadhav et al., 2019), but an effective tau treatment or a cure for AD and related dementias remain elusive. Here, MAPT is linked to dementia.